Steward Partners Investment Advisory’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $84.6K | Buy |
982
+437
| +80% | +$39.2K | ﹤0.01% | 2474 |
|
|
2025
Q4 | $47.6K | Sell |
545
-293
| -35% | -$22.2K | ﹤0.01% | 2698 |
|
|
2025
Q3 | $48K | Sell |
838
-64
| -7% | -$3.69K | ﹤0.01% | 2628 |
|
|
2025
Q2 | $53.2K | Sell |
902
-1,097
| -55% | -$70.9K | ﹤0.01% | 2442 |
|
|
2025
Q1 | $146K | Buy |
1,999
+1,820
| +1,017% | +$150K | ﹤0.01% | 1802 |
|
|
2024
Q4 | $14.8K | Sell |
179
-6
| -3% | -$473 | ﹤0.01% | 2926 |
|
|
2024
Q3 | $13.2K | Buy |
185
+13
| +8% | +$918 | ﹤0.01% | 2842 |
|
|
2024
Q2 | $11.8K | Sell |
172
-92
| -35% | -$5.5K | ﹤0.01% | 2751 |
|
|
2024
Q1 | $14.2K | Sell |
264
-70
| -21% | -$3.76K | ﹤0.01% | 2666 |
|
|
2023
Q4 | $17.8K | Hold |
334
| – | – | ﹤0.01% | 2460 |
|
|
2023
Q3 | $16.6K | Hold |
334
| – | – | ﹤0.01% | 2402 |
|
|
2023
Q2 | $19.9K | Buy |
334
+25
| +8% | +$1.43K | ﹤0.01% | 2293 |
|
|
2023
Q1 | $17.5K | Sell |
309
-168
| -35% | -$10.8K | ﹤0.01% | 2303 |
|
|
2022
Q4 | $35.4K | Buy |
477
+57
| +14% | +$3.88K | ﹤0.01% | 1972 |
|
|
2022
Q3 | $25K | Buy |
420
+84
| +25% | +$5.06K | ﹤0.01% | 2109 |
|
|
2022
Q2 | $19K | Sell |
336
-401
| -54% | -$26.4K | ﹤0.01% | 2241 |
|
|
2022
Q1 | $54K | Buy |
737
+453
| +160% | +$31.5K | ﹤0.01% | 1876 |
|
|
2021
Q4 | $21K | Hold |
284
| – | – | ﹤0.01% | 2301 |
|
|
2021
Q3 | $22K | Sell |
284
-164
| -37% | -$13.2K | ﹤0.01% | 2280 |
|
|
2021
Q2 | $35K | Sell |
448
-134
| -23% | -$9.53K | ﹤0.01% | 3953 |
|
|
2021
Q1 | $35.9K | Sell |
582
-14
| -2% | -$887 | ﹤0.01% | 2163 |
|
|
2020
Q4 | $39K | Hold |
596
| – | – | ﹤0.01% | 1782 |
|
|
2020
Q3 | $30K | Hold |
596
| – | – | ﹤0.01% | 1725 |
|
|
2020
Q2 | $28K | Sell |
596
-106
| -15% | -$5.11K | ﹤0.01% | 1648 |
|
|
2020
Q1 | $29K | Hold |
702
| – | – | ﹤0.01% | 1467 |
|
|
2019
Q4 | $41K | Sell |
702
-38
| -5% | -$2.06K | ﹤0.01% | 1484 |
|
|
2019
Q3 | $37K | Buy |
740
+102
| +16% | +$4.86K | ﹤0.01% | 1484 |
|
|
2019
Q2 | $26K | Buy |
+638
| New | +$27.7K | ﹤0.01% | 1599 |
|
|
2018
Q4 | – | Sell |
-638
| Closed | -$36K | – | 1313 |
|
|
2018
Q3 | $36K | Buy |
638
+144
| +29% | +$7.58K | ﹤0.01% | 1319 |
|
|
2018
Q2 | $25K | Buy |
494
+102
| +26% | +$5.32K | ﹤0.01% | 1375 |
|
|
2018
Q1 | $19K | Buy |
392
+244
| +165% | +$11.5K | ﹤0.01% | 1346 |
|
|
2017
Q4 | $6K | Hold |
148
| – | – | ﹤0.01% | 1462 |
|
|
2017
Q3 | $4K | Hold |
148
| – | – | ﹤0.01% | 1349 |
|
|
2017
Q2 | $4K | Hold |
148
| – | – | ﹤0.01% | 1272 |
|
|
2017
Q1 | $4K | Buy |
+148
| New | +$4.04K | ﹤0.01% | 1173 |
|
Other funds holding GMED
VCM
VPM
SC
Steward Partners Investment Advisory's GMED Position: Q1 2026 in Review
Steward Partners Investment Advisory increased its Globus Medical (GMED) stake by 80% in Q1 2026, buying an estimated $39.2K and bringing the position to 982 shares worth $84.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2474.
Steward Partners Investment Advisory first reported a position in GMED in Q1 2017 and has held it in 35 quarters since. The position peaked at $146K in Q1 2025. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- Steward Partners Investment Advisory held 982 shares of Globus Medical worth $84.6K as of Q1 2026.
- Steward Partners Investment Advisory bought 437 Globus Medical shares in Q1 2026, an estimated $39.2K.
- Globus Medical made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #2474 holding.
- Steward Partners Investment Advisory first reported a position in Globus Medical in Q1 2017 and has held it in 35 quarters since.
- Steward Partners Investment Advisory's Globus Medical position peaked at $146K in Q1 2025.
- 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.